Continuous manufacturing (CM) is transforming how medicines are developed and produced. When aligned with the needs of your product, CM can improve quality, reduce costs, and shorten time to market. Success depends on tailoring implementation to your product and regulatory pathway, whether for an innovator molecule, a generic, an OTC product, or a CDMO client. Pharmatech Associates, a USP company, brings science-backed CM guidance and decades of consulting expertise to help you evaluate, plan, and implement continuous processes with confidence. Our support spans business case development, process design, equipment selection, and implementation oversight
Every product presents unique CMC and manufacturing challenges. We work with you to design CM strategies that anticipate risks and create value across development and commercialization.
What you gain:
Batch processes remain the norm, but CM offers superior control, flexibility, and speed. Pharmatech helps you capture these benefits at every stage.
Our support includes:
Our expertise ensures your move to CM is not only efficient but also fully aligned with FDA, EMA, and other global agency expectations
If quality issues are slowing your program, CM can provide a solution. We assess your processes, identify bottlenecks, and guide implementation to ensure reliable outcomes.
Services include:
As environmental regulations tighten, sustainability is no longer optional. CM reduces waste, energy use, and variability while ensuring quality and compliance.
We help you:
Pharmatech Associates, a USP company, partners with you to create a CM strategy that reduces risk, improves quality, and accelerates market entry.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541
